Detailed Information
Cited 73 time in 
Cited 70 time in 
Cited 70 time in
Metadata Downloads
Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 3
- Authors
- Liakina, V.[Liakina, V.]; Hamid, S.[Hamid, S.]; Tanaka, J.[Tanaka, J.]; Olafsson, S.[Olafsson, S.]; Sharara, A.I.[Sharara, A.I.]; Alavian, S.M.[Alavian, S.M.]; Gheorghe, L.[Gheorghe, L.]; El Hassan, E.S.[El Hassan, E.S.]; Abaalkhail, F.[Abaalkhail, F.]; Abbas, Z.[Abbas, Z.]; Abdou, A.[Abdou, A.]; Abourached, A.[Abourached, A.]; Al Braiki, F.[Al Braiki, F.]; Al Hosani, F.[Al Hosani, F.]; Al Jaberi, K.[Al Jaberi, K.]; Al Khatry, M.[Al Khatry, M.]; Al Mulla, M.A.[Al Mulla, M.A.]; Al Quraishi, H.[Al Quraishi, H.]; Al Rifai, A.[Al Rifai, A.]; Al Serkal, Y.[Al Serkal, Y.]; Alam, A.[Alam, A.]; Alashgar, H.I.[Alashgar, H.I.]; Alawadhi, S.[Alawadhi, S.]; Al-Dabal, L.[Al-Dabal, L.]; Aldins, P.[Aldins, P.]; Alfaleh, F.Z.[Alfaleh, F.Z.]; Alghamdi, A.S.[Alghamdi, A.S.]; Al-Hakeem, R.[Al-Hakeem, R.]; Aljumah, A.A.[Aljumah, A.A.]; Almessabi, A.[Almessabi, A.]; Alqutub, A.N.[Alqutub, A.N.]; Alswat, K.A.[Alswat, K.A.]; Altraif, I.[Altraif, I.]; Alzaabi, M.[Alzaabi, M.]; Andrea, N.[Andrea, N.]; Assiri, A.M.[Assiri, A.M.]; Babatin, M.A.[Babatin, M.A.]; Baqir, A.[Baqir, A.]; Barakat, M.T.[Barakat, M.T.]; Bergmann, O.M.[Bergmann, O.M.]; Bizri, A.R.[Bizri, A.R.]; Blach, S.[Blach, S.]; Chaudhry, A.[Chaudhry, A.]; Choi, M.S.[Choi, M.S.]; Diab, T.[Diab, T.]; Djauzi, S.[Djauzi, S.]; El Khoury, S.[El Khoury, S.]; Estes, C.[Estes, C.]; Fakhry, S.[Fakhry, S.]; Farooqi, J.I.[Farooqi, J.I.]; Fridjonsdottir, H.[Fridjonsdottir, H.]; Gani, R.A.[Gani, R.A.]; Ghafoor Khan, A.[Ghafoor Khan, A.]; Goldis, A.[Goldis, A.]; Gottfredsson, M.[Gottfredsson, M.]; Gregorcic, S.[Gregorcic, S.]; Hajarizadeh, B.[Hajarizadeh, B.]; Han, K.H.[Han, K.H.]; Hasan, I.[Hasan, I.]; Hashim, A.[Hashim, A.]; Horvath, G.[Horvath, G.]; Hunyady, B.[Hunyady, B.]; Husni, R.[Husni, R.]; Jafri, W.[Jafri, W.]; Jeruma, A.[Jeruma, A.]; Jonasson, J.G.[Jonasson, J.G.]; Karlsdottir, B.[Karlsdottir, B.]; Kim, D.Y.[Kim, D.Y.]; Kim, Y.S.[Kim, Y.S.]; Koutoubi, Z.[Koutoubi, Z.]; Lesmana, L.A.[Lesmana, L.A.]; Lim, Y.S.[Lim, Y.S.]; Löve, A.[Löve, A.]; Maimets, M.[Maimets, M.]; Makara, M.[Makara, M.]; Malekzadeh, R.[Malekzadeh, R.]; Matičič, M.[Matičič, M.]; Memon, M.S.[Memon, M.S.]; Merat, S.[Merat, S.]; Mokhbat, J.E.[Mokhbat, J.E.]; Mourad, F.H.[Mourad, F.H.]; Muljono, D.H.[Muljono, D.H.]; Nawaz, A.[Nawaz, A.]; Nugrahini, N.[Nugrahini, N.]; Priohutomo, S.[Priohutomo, S.]; Qureshi, H.[Qureshi, H.]; Rassam, P.[Rassam, P.]; Razavi, H.[Razavi, H.]; Razavi-Shearer, D.[Razavi-Shearer, D.]; Razavi-Shearer, K.[Razavi-Shearer, K.]; Rozentale, B.[Rozentale, B.]; Sadik, M.[Sadik, M.]; Saeed, K.[Saeed, K.]; Salamat, A.[Salamat, A.]; Salupere, R.[Salupere, R.]; Sanai, F.M.[Sanai, F.M.]; Sanityoso Sulaiman, A.[Sanityoso Sulaiman, A.]; Sayegh, R.A.[Sayegh, R.A.]; Schmelzer, J.D.[Schmelzer, J.D.]; Sibley, A.[Sibley, A.]; Siddiq, M.[Siddiq, M.]; Siddiqui, A.M.[Siddiqui, A.M.]; Sigmundsdottir, G.[Sigmundsdottir, G.]; Sigurdardottir, B.[Sigurdardottir, B.]; Speiciene, D.[Speiciene, D.]; Sulaiman, A.[Sulaiman, A.]; Sultan, M.A.[Sultan, M.A.]; Taha, M.[Taha, M.]; Tarifi, H.[Tarifi, H.]; Tayyab, G.[Tayyab, G.]; Tolmane, I.[Tolmane, I.]; Ud Din, M.[Ud Din, M.]; Umar, M.[Umar, M.]; Valantinas, J.[Valantinas, J.]; Videčnik-Zorman, J.[Videčnik-Zorman, J.]; Yaghi, C.[Yaghi, C.]; Yunihastuti, E.[Yunihastuti, E.]; Yusuf, M.A.[Yusuf, M.A.]; Zuberi, B.F.[Zuberi, B.F.]; Gunter, J.[Gunter, J.]
- Issue Date
- 2015
- Keywords
- diagnosis; disease burden; epidemiology; hepatitis C; hepatitis C virus; historical; incidence; mortality; prevalence; treatment
- Citation
- Journal of Viral Hepatitis, v.22, pp.4 - 20
- Journal Title
- Journal of Viral Hepatitis
- Volume
- 22
- Start Page
- 4
- End Page
- 20
- Abstract
- Detailed, country-specific epidemiological data are needed to characterize the burden of chronic hepatitis C virus (HCV) infection around the world. With new treatment options available, policy makers and public health officials must reconsider national strategies for infection control. In this study of 15 countries, published and unpublished data on HCV prevalence, viraemia, genotype, age and gender distribution, liver transplants and diagnosis and treatment rates were gathered from the literature and validated by expert consensus in each country. Viraemic prevalence in this study ranged from 0.2% in Iran and Lebanon to 4.2% in Pakistan. The largest viraemic populations were in Pakistan (7 001 000 cases) and Indonesia (3 187 000 cases). Injection drug use (IDU) and a historically unsafe blood supply were major risk factors in most countries. Diagnosis, treatment and liver transplant rates varied widely between countries. However, comparison across countries was difficult as the number of cases changes over time. Access to reliable data on measures such as these is critical for the development of future strategies to manage the disease burden. © 2015 John Wiley & Sons Ltd.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.